Immunological Results of Long-Term Use of Mammalian Target of Rapamycin (mTOR) Inhibitors and Its Effects on Renal Graft Functions

Mehmet Tanrısev; Tülay Ayna Kılıçaslan; Hülya Çolak; Sibel Ersan; Banu Yılmaz; Alper Alp; Cem Tuğmen; Bahar Engin Sevgili

doi:10.12659/AOT.932434

17 September 2021: Original Paper

Immunological Results of Long-Term Use of Mammalian Target of Rapamycin (mTOR) Inhibitors and Its Effects on Renal Graft Functions

Mehmet Tanrısev ^1ABCDEF* , Tülay Ayna Kılıçaslan ^2CD , Hülya Çolak ^1BFG , Sibel Ersan ^1BD , Banu Yılmaz ^1BFG , Alper Alp ^3B , Cem Tuğmen ^4BC , Bahar Engin Sevgili ^5E

DOI: 10.12659/AOT.932434

Ann Transplant 2021; 26:e932434

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Table 2 Biochemical analysis features of the study groups.

Variables	mTOR group (n=37) mean±SD	CNI group (n=52) mean±SD	p
Post-transplant creatinine (mg/dl)	1.20±0.3	1.30±0.3	0.060
Actual creatinine (mg/dl)	1.32±0.5	1.43±0.5	0.330
Post-transplant eGFR (ml/min per/1.73 m)	67.4±16	63±12.8	0.230
Actual eGFR (ml/min per/1.73 m)	59.7±20	57±17	0.520
Post-transplant spot urine protein/creatinine	0.1±0.2	0.14±0.3	0.110
Actual spot urine protein/creatinine	0.3±0.5	0.28±1.0
Independent t test was used and P

Back to the Article

Immunological Results of Long-Term Use of Mammalian Target of Rapamycin (mTOR) Inhibitors and Its Effects on Renal Graft Functions

Your Privacy